InfectoPharm at Pharma Conference: Leader in the German Paediatric Field

Pharma Conference

InfectoPharm Arzneimittel und Consilium GmbH, that will be participating at the Pharma Conference PharmaVenue, is a leading pharmaceutical company in the German paediatric field. For the last consecutive 20 years, the company has received the award “goldene Tablette” from the German paediatrician society for its innovative drugs and services.

Founded in 1988, InfectoPharm is a family-owned business engaged in the development and commercialization of prescription and non-prescription medicines for paediatric therapeutic areas such as infectiology, dermatology, pneumology, and allergology as well as hospital antibiotics.

Working in Partnership with Paediatricians

InfectoPharm Arzneimittel und Consilium GmbH is a company that has established itself as a leading pharmaceutical company in the German paediatric field, and this is in large part due to the company’s strong commitment to working in partnership with paediatricians. Consequently, the company has been collaborating with paediatricians for over 30 years, and it has developed a deep understanding of their unique needs and the specific challenges that come with treating children. In additiona, InfectoPharm has used this knowledge to develop a range of specialties that are tailored to paediatricians’ therapeutic needs and children’s compliance demand.

One of the ways in which InfectoPharm has worked with paediatricians is by involving them in the research and development of new drugs. Thereofre, the company has a dedicated research team that works closely with paediatricians to identify unmet medical needs and develop innovative solutions to address them. Actually, this collaboration has led to the development of several successful drugs that have been well-received by both paediatricians and patients.

Hence, InfectoPharm’s commitment to working in partnership with paediatricians is also reflected in the company’s approach to clinical trials. The company places a strong emphasis on conducting rigorous clinical trials to prove the efficacy and safety of its products. These trials are conducted in collaboration with paediatricians and are designed to meet the unique needs of children.

Paediatric and Hospital Products Portfolio

In addition to developing drugs, InfectoPharm has also developed a range of medical devices and other products that are specifically designed for use in paediatric care. These products are designed to be easy to use and are tailored to meet the needs of paediatric patients.

Dermatology Products

InfectoPharm offers an anti-lice product (Medical Device Class I – with dimeticone), a unique painless treatment for molluscum contagiosum (Medical Device Class IIq – with potassium hydroxid), a topical treatment for primary skin infections (impetigo, folliculitis, furunculosis..) and secondary infections (Rx – API: Mupirocin), basic skin care as maintenance treatment in case of atopic dermatitis, psoriasis, and dry skin conditions (cosmetics), skin care with ceramides for an acceleration of the skin barrier repair (cosmetic), and natural care for cradle cap (cosmetic).

Pain Products

Additionally, InfectoPharm offers a unique Naproxen oral solution for the treatment of painful conditions such as arthritis, sprains, stains, backache, period (menstrual) pain, and gout pain (Rx – API: Naproxen).

Respiratory Diseases Products

Furthermore, the company also offers a unique oral formulation for the treatment of Bronchitis/Asthma (Rx – API: Salbutamol), a unique oral dexamethasone solution for the treatment of croup (swelling of the upper respiratory tracts below the glottis), and a unique antitussive medication as an oral suspension (Rx -API: Noscapine).

ENT Products

Likewise, InfectoPharm offers ear drops with glycerol to prevent and alleviate earache e.g. swim ears – otitis externa (Medical device Class I), ear drops with phenazone and procaine for the local, symptomatic treatment of pain in the external auditory canal (OTC – API: Phenazone & Procaine), and ipratropium bromide nasal spray for the symptomatic treatment of rhinorrhoea (Rx – API: Ipratropium bromide). These ENT products provide effective relief for common ear and nasal conditions. The ear drops with glycerol are especially useful for preventing and alleviating swimmer’s ear, a common condition among children who spend a lot of time in the water. The ear drops with phenazone and procaine offer fast-acting relief for ear pain, while the ipratropium bromide nasal spray can help ease the symptoms of runny nose associated with conditions such as hay fever and the common cold.

Overall, InfectoPharm is committed to developing innovative products that meet the needs of both healthcare professionals and patients. The company’s ENT product line is no exception, with a range of effective treatments for common ear and nasal conditions. With its focus on quality and innovation, InfectoPharm is a trusted partner for healthcare professionals around the world.

Hospital Products

InfectoPharm’s hospital products are designed to support healthcare professionals in the treatment of serious infections. The company offers fosfomycin i.v., which is used to treat nosocomial infections, skin and soft tissue infections, osteomyelitis, and respiratory infections. The medication is effective even under difficult circumstances and can help to avoid the development of resistance.

In addition, InfectoPharm provides unique oral dexamethasone solution for the treatment of croup, which is a swelling of the upper respiratory tracts below the glottis. This medication is particularly useful in hospital settings, where patients may require more intensive treatment.

Finally, the company also offers Mupirocin calcium 2% nasal ointment, which is used to eradicate nasal colonization with MRSA. This medication is essential in hospital settings, where infections can spread rapidly and easily between patients.

Infectopharm at Pharma Conference PharmaVenue

Attending PharmaVenue, a networking and partnering event that offers a 6-week pre-event networking and matchmaking phase and 2 days of in-person one-on-one meetings, can provide numerous benefits for companies like InfectoPharm.

First and foremost, participating in PharmaVenue can help InfectoPharm expand its network and connect with potential business partners from different parts of the world. This can open up new opportunities for collaboration, such as partnerships for distribution, licensing, or joint development of products.

Moreover, attending the event can provide an excellent platform for InfectoPharm to showcase its products, services, and expertise to a wider audience. This can help the company build its brand and reputation, and increase its visibility in the pharmaceutical industry.

Additionally, the pre-event networking and matchmaking phase of PharmaVenue can enable InfectoPharm to identify and prioritize potential partners for one-on-one meetings during the event. This can help the company make the most of its time and resources, and ensure that it meets with the most relevant and promising partners.

Overall, attending PharmaVenue can be a valuable investment for InfectoPharm, offering opportunities for networking, partnership, and growth. By participating in the event, the company can strengthen its position in the market, expand its reach, and explore new avenues for innovation and collaboration.